114 related articles for article (PubMed ID: 18165112)
21. A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy.
Al-Nammari SS; Timothy T; Afsie S
Foot Ankle Surg; 2013 Dec; 19(4):212-7. PubMed ID: 24095226
[TBL] [Abstract][Full Text] [Related]
22. Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
Das L; Rastogi A; Jude EB; Prakash M; Dutta P; Bhansali A
PLoS One; 2021; 16(11):e0259224. PubMed ID: 34748565
[TBL] [Abstract][Full Text] [Related]
23. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial.
Bem R; Jirkovská A; Fejfarová V; Skibová J; Jude EB
Diabetes Care; 2006 Jun; 29(6):1392-4. PubMed ID: 16732029
[No Abstract] [Full Text] [Related]
24. Acute neuropathic joint disease: a medical emergency?
Jeffcoate WJ; Game FL; Armstrong DG; Cavanagh PR
Diabetes Care; 2006 Apr; 29(4):951-2; author reply 952. PubMed ID: 16602195
[No Abstract] [Full Text] [Related]
25. What is new in the treatment of steroid-induced osteoporosis?
Liu RH; Werth VP
Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
[TBL] [Abstract][Full Text] [Related]
26. Giant osteoclast formation and long-term oral bisphosphonate therapy.
Jobke B
N Engl J Med; 2009 Apr; 360(16):1676; author reply 1677-8. PubMed ID: 19369677
[No Abstract] [Full Text] [Related]
27. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Gnant M; Dubsky P; Fitzal F; Blaha P; Schoppmann S; Steger G; Marth C; Samonigg H; Hüttner K; Fohler H; Ruecklinger E; Jakesz R; Greil R;
Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S18-27. PubMed ID: 19561003
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?
Selby PL; Young MJ; Boulton AJ
Diabet Med; 1994; 11(1):28-31. PubMed ID: 8181248
[TBL] [Abstract][Full Text] [Related]
29. Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series.
Armamento-Villareal R; Napoli N; Diemer K; Watkins M; Civitelli R; Teitelbaum S; Novack D
Calcif Tissue Int; 2009 Jul; 85(1):37-44. PubMed ID: 19548019
[TBL] [Abstract][Full Text] [Related]
30. Medical image. A sequel of deranged metabolic control. Diabetes mellitus.
Kumar N; Cheung YC; Varughese GI; Benn JJ; Willis AC
N Z Med J; 2008 Jan; 121(1268):U2900. PubMed ID: 18256715
[No Abstract] [Full Text] [Related]
31. [Bisphosphonates and osteonecrosis of the jaw].
Saussez S; Filleul O; Loeb I
Rev Stomatol Chir Maxillofac; 2008 Dec; 109(6):367-73. PubMed ID: 19013624
[TBL] [Abstract][Full Text] [Related]
32. How effective is bisphosphonate treatment for preventing bone fractures after liver transplantation?
Hay JE
Nat Clin Pract Gastroenterol Hepatol; 2008 Apr; 5(4):190-1. PubMed ID: 18268522
[No Abstract] [Full Text] [Related]
33. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
34. New results from the use of bisphosphonates in cancer patients.
Coleman R; Gnant M
Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
[TBL] [Abstract][Full Text] [Related]
35. Effects of bisphosphonates on lipid metabolism.
Guney E; Kisakol G; Ozgen AG; Yilmaz C; Kabalak T
Neuro Endocrinol Lett; 2008 Apr; 29(2):252-5. PubMed ID: 18404138
[TBL] [Abstract][Full Text] [Related]
36. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
Woodis CB
Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
[TBL] [Abstract][Full Text] [Related]
37. Charcot neuro-osteoarthropathy-current standards.
Petrova NL; Edmonds ME
Diabetes Metab Res Rev; 2008; 24 Suppl 1():S58-61. PubMed ID: 18442182
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of osteoporosis in octogenarians].
Pepersack T
Rev Med Brux; 2008 Sep; 29(4):311-6. PubMed ID: 18949982
[TBL] [Abstract][Full Text] [Related]
39. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
40. [Arthritis as a consequence of diabetes mellitus or haemochromatosis].
Huisman AM; de Valk HW; Prins HJ; Bijlsma JW; Jacobs JW
Ned Tijdschr Geneeskd; 2005 Jan; 149(4):196-200. PubMed ID: 15702739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
